Andrew Huberman· PhD
Fascinating data on how the experience of anxiety, feelings of “mystical-level boundlessness”, dissolution of self & the return to calm & self identification, each relate to therapeutic benefits of psilocybin.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Fascinating data on how the experience of anxiety, feelings of “mystical-level boundlessness”, dissolution of self & the return to calm & self identification, each relate to therapeutic benefits of psilocybin.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And, again, I can't underscore this enough because it's been told to me over and over again by the top researchers in this area. That people head into that peaking phase of the psilocybin journey, and oftentimes it is not pleasant for them, they're feeling like it's uncomfortable, it's scary, and their heart rate is up, and their blood pressure is up, and they're having a hard time calming down, and they want to calm down. But it does seem that while the guides should not ramp them up and get them more stressed, that the ability to move through that stressful period to somewhat guide oneself or to be encouraged to guide oneself through that peak. And that anxiety and the fear of losing oneself and the so-called ego dissolution that occurs is an important feature for an effective therapeutic session.